Neurorehabilitation Survey on COVID-19: Insights on Neurological Complications
"Survey conducted by WFNR Task Force members to understand the impact of COVID-19 on neurorehabilitation professionals treating patients with neurological complications. The survey addresses neurological manifestations, patient influence, and neuropsychological impacts. It includes responder rates, infographic on infected and deceased individuals in various countries, and a comprehensive list of neurological manifestations and psychological symptoms observed in treatment participants."
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
WFNR Survey for COVID-19 Survey Task Force Members Izumi Kondo, Japan (Chair), Marta Imamura (Brazil), Sabahat Wasti (United Arab Emirates), Caterina Pistarini (Italy) The main objective of this survey is to learn about the experience of neurorehabilitation professionals who provide neurorehabilitation to victims of COVID-19 with neurological complications. The survey is not limited to the professionals who directly treat patients with Corona virus infection. 2. This survey addresses following three important issues: 1) Neurological Manifestation 2) The influence to the patients with COVID-19 and the patients with neurological disease but without infection 3) Neuropsychological impact of COVID-19 infection on patients and stress factor on staff engaged in neurological treatment
Methods Survey was performed with using web system and the link to questionnaire was sent to the representatives of national society in WFNR Questionnaire had 50 items containing free ending format answers It begun on 11thMarch 2021 and ended on 30thApril Survey period https://www.worldometers.info/coronavirus/?utm_campaign=homeAdUOA?Si
Responder / Treatment Participant Rate Responder Rate of Treatment Participant N=197 (%) 70 100 90 60 80 50 70 60 40 50 30 40 30 20 20 10 10 0 0 Turkey Japan Indonesia France Spain S. Korea Other Spain Turkey France Indonesia Japan S. Korea Praticipant No Participant Participant No Praticipant
Number of people infected and dead with COVID-19 in 6 countries until 9thAug 2021 Infected Dead 8,000,000 160000 7,000,000 140000 6,000,000 120000 5,000,000 100000 4,000,000 80000 3,000,000 60000 2,000,000 40000 1,000,000 20000 0 0 Spain Turkey France Spain France Turkey Indonesia Indonesia Japan S. Korea
Neurological Manifestations and Psychological Symptom 120 From Treatment Participant N=124 100 80 60 40 20 0 Muscle pain/fatigue Stroke Anxiety Depression Reduced concentration Pressure ulcers Dysphagia Sleep disturbances Impaired memory Difficulties in learning new skills Apathy Brain fog Dysautonomia Alzheimer disease Others Post intensive care syndrome (PICS) Peripheral neuropathies Stress Neuropathic Pain Delirium and Cognitive impairments Loss of smell/taste Attention deficits Post-traumatic stress Guillain Barre Syndrome Confusion Brain stem (cardiac and respiratory impairments) Seizure and encephalopathies Multiple sclerosis and other demyelinating diseases Meningitis Parkinson s Disease
Influence to Patients with COVID-19 itself and Patients with Neurological diseases Q9. At the phase of emergency or contaminating phase, Does COVID-19 status of patients cause first contacts to be delayed? Q 16. Do COVID-19 status of patients have an impact on their potential outcomes? Q13. In patients without COVID-19 who need isolation to protect them from COVID-19, does it interfere with treatments and interventions? 80 120 120 From Treatment Participant N=127 From Treatment Participant N=126 From All Responder N=191 70 100 100 60 80 80 50 40 60 60 30 40 40 20 20 20 10 0 0 0 Yes No Don"t know Yes No Don't know Yes No Don't know
Impact on Inpatient, Outpatient and Community Based Neurorehabilitation Q22. On Inpatient Neurorehabilitation Service Q 31 On Outpatient Neurorehabilitation Service Q39. On Community Based Neurorehabilitation Service 180 180 180 All respondent N=191 All respondent N=187 All respondent N=192 160 160 160 140 140 140 120 120 120 100 100 100 80 80 80 60 60 60 40 40 40 20 20 20 0 0 0 Yes No Don"t know Yes No Don't know Yes No Don't know
Impact on Inpatient Neurorehabilitation Service Q26. If there is impact: Has your work decreased ? Q27: If Yes for Q26: Is it due to: Resources have been re- allocated to acute care Q28: Have the staff been redeployed to to acute care 120 140 60 N=189 N=188 N=116 100 120 50 100 80 40 80 60 30 60 40 20 40 20 10 20 0 0 0 Yes No Don"t know Yes No Don't know Yes No Don't know
Impact on Outpatient Neurorehabilitation Service Q32. Has it become less busy ? Q33: If Yes for Q32: Patients want to come but cannot due to restrictions Q35: If Yes for Q32: Has the staff been redeployed 100 120 140 90 N=189 N=157 N=156 120 100 80 70 100 80 60 80 50 60 60 40 40 30 40 20 20 20 10 0 0 0 Yes No Don"t know Yes No Don't know Yes No Don't know
Impact on Community Based Neurorehabilitation Service Q40: If there is impact, Is it due to: Local regulations restricting visits? Q41: Is it due to reluctance of patients and their families to allow visits by neurorehabilitation staff? Q42: Is it due to reluctance of staff to go out on visits? N=158 N=153 140 140 N=157 140 120 120 120 100 100 100 80 80 80 60 60 60 40 40 40 20 20 20 0 0 0 Yes No Don"t know Yes No Don't know Yes No Don't know
Summary Situation of countries attended this survey is variable according to number of patient, government policy and provided treatment, so care must to be taken into account for the interpretation of the results Among neurological manifestation, treatment participants encountered muscle pain/fatigue, stroke and peripheral neuropathy frequently. As regards to psychological symptom, anxiety, stress, depression are often observed. Neurorehabilitation service on inpatient, outpatient and community based setting were suffered much by COVID-19 with the various reason.
